Please login to the form below

Not currently logged in
Email:
Password:

New medical animation company launched

Fusion Medical Animation, a new company specialising in drug mode of action (MOA) animation has been founded by Simon Reid, the former director of production at Random42
Fusion Medical Animation, a new company specialising in drug mode of action (MOA) animation for the pharma, research and healthcare industries has been founded by Simon Reid, the former director of production at Random42. 

MOA animations communicate the biochemical interaction through which a drug substance produces its pharmacological effect. Targeted at physicians, Fusion's animations can lead to greater awareness and adoption of clients' products.

With photo-real animation now common place in film, television and increasingly online, pharma clients are beginning to expect this sort of quality animation and CGI, to explain and market their new drugs and products.

An example of Fusion's MOA animation



Fusion's unique position allows them to combine feature film quality graphics, along with scientifically accurate pharmaceutical MOA expertise.

Before moving to the pharmaceutical industry as director of production at a leading MOA animation agency, Reid spent many years setting up and running various visual effects departments for factual broadcast. 

In addition to their work in the pharmaceutical arena, Fusion has worked on the landmark BBC science series "First Life" presented by Sir David Attenborough as well as producing the medical/science shots for another Attenborough documentary, "Flying Monsters", a stereoscopic production for the new Sky 3D channel and IMAX theatres. 

5th January 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics